News by subject: Stock Sale/Buyback

Fluor Corporation ("Fluor" or the "Company") today announced the pricing of $500 million aggregate principal amount of 1.125% Convertible Senior Notes due 2029 (the "Notes") in a private offering (the "Offering"). In connection with the Offering,...

DoubleVerify Holdings, Inc. ("DoubleVerify") today announced the pricing of an underwritten offering of 12,500,000 shares of its common stock by Providence VII U.S. Holdings L.P. and Providence Butternut Co-Investment L.P. (collectively,...

Hercules Capital, Inc. ("Hercules") today announced that it has priced its upsized public offering of 6,500,000 shares of its common stock. Hercules has also granted the underwriters an option to purchase up to an additional 975,000 shares of its...

DoubleVerify Holdings, Inc. ("DoubleVerify") today announced the launch of an underwritten offering of 12,500,000 shares of its common stock by Providence VII U.S. Holdings L.P. and Providence Butternut Co-Investment L.P. (collectively,...

Hercules Capital, Inc. ("Hercules") today announced that it plans to make a public offering of 6,000,000 shares of its common stock. Hercules also expects to grant the underwriters for the offering an option to purchase up to an additional 900,000...

Primerica, Inc. today announced financial results for the quarter ended June 30, 2023. Total revenues of $688.4 million increased 3% compared to the second quarter of 2022. Net income attributable to Primerica of $144.5 million increased 13%, while...

Palantir Technologies Inc. today announced financial results for the second quarter ended June 30, 2023. Q2 2023 Highlights GAAP net income of $28 million Third consecutive quarter of GAAP profitability GAAP income from operations of...

Vertiv Holdings Co ("Vertiv") , a global provider of critical digital infrastructure and continuity solutions, today announced the pricing of the previously announced underwritten secondary offering of 20,000,000 shares of Vertiv's Class A common...

Oragenics, Inc. ("Oragenics" or the "Company"), biotech company dedicated to fighting infectious diseases including coronaviruses, today announced it has entered into definitive agreements with two healthcare-focused investors, in which the Company...

Vertiv Holdings Co ("Vertiv") , a global provider of critical digital infrastructure and continuity solutions, today announced the commencement of an underwritten secondary offering of up to 20,000,000 shares of Vertiv's Class A common stock by VPE...

Tivic Health® Systems, Inc. ("Tivic", "Company", Nasdaq: TIVC), a health tech company that develops and commercializes bioelectronic medicine, today announced the pricing of its previously announced public offering of 33,173,000 shares of its common...

Herbalife Ltd. , a premier health and wellness company, announced today that, as previewed in its August 2, 2023 press release, and as a material inducement to Mr. Stephan Gratziani agreeing to become employed by the Company, the Company has granted...

Astra Space, Inc. ("Astra") announced today that it has closed a registered issuance of $12.5 million aggregate principal amount of senior secured notes (the "Notes") and warrants (the "Warrants") to purchase up to 22.5 million shares of Astra's...

Savara Inc. , a clinical stage biopharmaceutical company focused on rare respiratory diseases, today announced the grant of inducement awards to three new employees. On August 3, 2023, the Compensation Committee of Savara's Board of Directors...

Kezar Life Sciences, Inc., , a clinical-stage biotechnology company discovering and developing breakthrough treatments for immune-mediated and oncologic disorders, today announced that the Compensation Committee of the company's Board of Directors...

Tivic Health® Systems, Inc. ("Tivic Health", Nasdaq: TIVC), a health tech company that develops and commercializes bioelectronic medicine, today announced that it intends to offer and sell shares of its common stock in a public offering. All of the...

Cybin Inc. (NEO:CYBN) ("Cybin" or the "Company"), a clinical-stage biopharmaceutical company committed to revolutionizing mental healthcare by developing new and innovative psychedelic-based treatment options, is pleased to announce that it has...

Hayward Holdings, Inc. (the "Company" or "Hayward"), a global designer, manufacturer and marketer of a broad portfolio of pool and outdoor living technology, today announced the pricing of the previously announced underwritten public offering (the...

Seres Therapeutics, Inc. ("Seres" or the "Company"), a leading microbiome therapeutics company, today announced that on July 31, 2023, the Compensation and Talent Committee of Seres' board of directors granted inducement equity grants covering an...

QuantumScape Corporation , a leader in developing next-generation solid-state lithium-metal batteries, today announced the pricing of an underwritten public offering of 37,500,000 shares of its Class A common stock (the "Shares") for gross proceeds...

Walgreens Boots Alliance, Inc. today announced that it has sold shares of AmerisourceBergen Corporation ("AmerisourceBergen") common stock pursuant to prepaid variable share forward transactions executed through a registered public offering for...

Hayward Holdings, Inc. (the "Company" or "Hayward"), a global designer, manufacturer and marketer of a broad portfolio of pool and outdoor living technology, today announced the pricing of the previously announced underwritten public offering (the...

General American Investors Company, Inc., a closed-end investment company listed on the New York Stock Exchange (GAM), filed with the U.S. Securities and Exchange Commission (SEC) its Certified Shareholder Report (Form N-CSR) for the six month period...

AmerisourceBergen Corporation (the "Company") announced today a registered public offering of 10.5 million shares of common stock of the Company in connection with Walgreens Boots Alliance Holdings LLC (the "Selling Stockholder") entering into...

Eagle Point Income Company Inc. (the "Company") today announced, in connection with its previously disclosed underwritten public offering of 1,130,500 shares of its 7.75% Series B Term Preferred Stock due 2028 (the "Preferred Stock") at a public...

PCB Bancorp (the "Company") , the holding company of PCB Bank, announced that on August 2, 2023, its Board of Directors approved a stock repurchase program authorizing the repurchase of up to 720,000 shares of the Company's outstanding common stock,...

MACOM Technology Solutions Holdings, Inc. ("MACOM") , a leading supplier of semiconductor products, today announced that it has utilized approximately $121 million of its $588 million of available cash and short-term investments as of June 30, 2023...

Dream Finders Homes, Inc. (the "Company," "Dream Finders Homes," "Dream Finders" or "DFH") announced its financial results for the second quarter ended June 30, 2023. Second Quarter 2023 Highlights (As Compared to Second Quarter 2022, unless...

U.S. Bancorp announced plans to issue 24 million shares of U.S. Bancorp common stock to an affiliate of Mitsubishi UFJ Financial Group, Inc. (MUFG) for an aggregate purchase price of $936 million. The proceeds will be used by U.S. Bancorp to satisfy...

Lomiko Metals Inc. (the "Company") announces that it has closed off its private placement and was successful in raising $401,000 through the issuance of 13,366,666 units at $0.03. Each unit consists of one common share and one warrant exercisable at...

KalVista Pharmaceuticals, Inc. , today announced the grant of an inducement award to the Company's recently appointed Chief Commercial Officer, Nicole Sweeny. In connection with Ms. Sweeny's appointment, the compensation committee of KalVista's board...

QuantumScape Corporation , a leader in developing next-generation solid-state lithium-metal batteries, today commenced a proposed underwritten public offering of shares of its Class A common stock. QuantumScape intends to offer $300 million of...

Equillium, Inc. , a clinical-stage biotechnology company leveraging a deep understanding of immunobiology to develop novel therapeutics to treat severe autoimmune and inflammatory disorders, today announced that its Board of Directors authorized the...

Regulatory News: Teleperformance (Paris:TEP), a global leader in digital business services, today announced it has decided to launch a share buyback program for a total amount of up to ?500 million that is scheduled to run from August 3rd, 2023 to...

Cyclo Therapeutics, Inc. ("Cyclo Therapeutics" or the "Company"), a clinical stage biotechnology company dedicated to developing life-changing medicines through science and innovation for patients and families living with diseases, today announced...

Frontier Communications Parent, Inc. ("Frontier" or the "Company") today announced that a limited-purpose, bankruptcy remote, indirect subsidiary of the Company (the "Issuer") has priced $1.586 billion of aggregate principal amount of secured fiber...

Acadia Pharmaceuticals Inc. today announced that on July 18, 2023, the Compensation Committee of Acadia's Board of Directors (the "Committee") granted inducement awards consisting of non-qualified stock options to purchase 19,903 shares of common...

Ares Acquisition Corporation ("AAC" or the "Company") today announced its shareholders approved a further extension of the period of time that the Company has to consummate its proposed business combination (the "Business Combination") with X-Energy...

Cybin Inc. (NEO:CYBN) ("Cybin" or the "Company"), a clinical-stage biopharmaceutical company committed to revolutionizing mental healthcare by developing new and innovative psychedelic-based treatment options, announced today the pricing of its...

Ferguson plc (the "Company") announces today that it purchased a total of 39,722 of its ordinary shares in the period from July 24, 2023, up to and including July 28, 2023, in connection with its $3.0 billion share repurchase program. Aggregated...

Nidec Corporation (TOKYO: 6594; OTC US: NJDCY) (the "Company") today announced the status of the Company's own share repurchase under its ongoing repurchase plan resolved at a meeting of the Board of Directors held on January 24, 2023, pursuant to...

Genworth Financial, Inc. today announced that its Board of Directors authorized the company to repurchase an additional $350 million of shares of its Class A common stock under its existing share repurchase program. As of July 31, 2023,...

Invitation Homes Inc. ("Invitation Homes" or the "Company") announced today that its operating partnership, Invitation Homes Operating Partnership LP (the "Operating Partnership"), has priced a public offering of $450 million aggregate principal...

On July 28, 2023, at its regular quarterly meeting, the Board of Directors of Crawford & Company® declared an increased quarterly dividend from $0.06 per share to $0.07 per share on both the Class A and Class B Common Stock, payable on September 1,...

Valaris Limited ("Valaris" or the "Company") announced today that it has been awarded a 12-well contract offshore West Africa for drillship VALARIS DS-7, which will be reactivated for this contract. The Company also announced that it is increasing...

UroGen Pharma Ltd. a biotech company dedicated to developing and commercializing innovative solutions that treat urothelial and specialty cancers, today announced the grants of inducement restricted stock units ("RSUs") and options ("Options") to a...

The Central and Eastern Europe Fund, Inc. , The European Equity Fund, Inc. , and The New Germany Fund, Inc. (each, a "Fund," and collectively, the "Funds") each announced today that its Board of Directors has approved an extension of the current...

Horizon Therapeutics plc : IRISH TAKEOVER PANEL DEALING DISCLOSURE UNDER RULE 8.1(c) AND (d)(i) OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2022 BY AN OFFEROR, OFFEREE OR PARTIES ACTING IN CONCERT WITH THEM IN RESPECT OF DEALINGS FOR...

International General Insurance Holdings Ltd. ("IGI" or the "Company") today announced that it has commenced an offer to purchase (the "Offer") all of its outstanding public warrants and private warrants (collectively, the "Warrants") to purchase...

Clarion Partners Real Estate Income Fund Inc. ("CPREIF" or the "Fund"), which offers Class S Shares (CPRSX), Class T Shares (CPRTX), Class D Shares (CPRDX) and Class I Shares (CPREX), announced today that the Fund's Board of Directors has approved a...